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Cervical carcinoma has been the subject of much interest due to its etiologic relation with an infective cause. As immunotherapy and vaccination took center stage as the latest therapy geared against cervical carcinoma, it is important to have a full understanding of the immune response in the uterine cervix.
In Malaysia, cervical cancer is the second leading cancer in females, following breast cancer. Based on the Malaysian National Cancer Registry, it makes up 12.9% of all cancers affecting the female population (1) . The association between certain strains of human papillomavirus (HPV) and cervical cancer is well known. It is the most common of the virus-associated cancers worldwide, followed by hepatocellular carcinoma, nasopharyngeal carcinoma, and Burkitt's lymphoma.
A normal ectocervix is lined by stratified squamous epithelium whereas the endocervix is lined by tall columnar epithelium. HPV has the tendency to confine itself to the squamous epithelial layer of the cervix. It is implicated in the development of dysplasia or cervical intraepithelial neoplasia and the progress to squamous cell carcinoma (2) .
Although Paul Langerhans reported the presence of epithelial dendritic cells in the skin as a medical student in 1868, only recently have the cells attracted widespread interest. Dendritic cells are immune cells and form part of the human immune system. These cells are normally present at a low frequency in organs that are in contact with the environment, such as the skin and the lining of nose, the lung, the stomach, and the intestines. In certain stages they have long spiky arms, which are called dendrites. Due to the confinement of the HPV infection within the epithelial layer, the presence of dendritic cells or Langerhans cells in the epithelial layer of the ectocervix is paramount in producing immune response.
Since the 1980s, there has been a growing interest in the study of dendritic cells in the uterine cervix (3). Dendritic cells have been established as the most potent antigen-presenting cell in the human body. Researchers have found that there are two entities of dendritic cells that differ phenotypically and functionally, namely, the mature and immature dendritic cells (4, 5) . The immature subgroup is excellent in the antigen uptake but is a poor antigen presenter, and the reverse is true for the mature subgroup. The differing character in these two populations of cells is the accessory molecule expression that can be studied immunohistochemically.
The mature dendritic cells express CD83 and high CD40/80/86 whilst the immature cells express CD1a and low CD40/80/86 (4). By identifying CD1a and CD83, theoretically, both immature and mature dendritic cell populations can be studied (6) .
Dendritic cells require a maturation step that promotes antigen presentation to prime the T cell activity, thus triggering the immune response (5) . Inhibition of the maturation of dendritic cell by malignant cells, as seen in melanoma and multiple myeloma, results in functional failure of the immune system (7) .
Researchers who studied the population of the dendritic cells in cervical lesions have shown that the number of dendritic cell increases with the increase in the grade of cervical dysplasia (8 Y 12) . However, in contrast, results from analysis of inflammatory infiltrates in cervical dysplasia have revealed reduced numbers of Langerhans cells in CIN II and CIN III (13, 14) . It has been generally accepted that dendritic cells are the most efficient antigen presenting cells of the immune system, thus in theory, their lack could result in an inefficient primary immune response (15) .
Extensive studies on dendritic cells have emphasized breast carcinoma, which is a much more common malignancy in women. In breast carcinoma, immature dendritic cells reside within the tumor, whilst mature dendritic cells are located in peritumoral areas (6) . It was confirmed that infiltration of tumors by mature CD83-expressing dendritic cells is a prognostic parameter for survival in patients with breast cancer (16) .
The recent advances in the treatment of cervical dysplasia by vaccination have directed the research towards the cellular and molecular components in the uterine cervix. The common theme to all the strategies of the therapeutic vaccine is to induce antigen presenting cells (APCs) to process viral antigen. One of the vaccines being developed currently is a dendritic cell-based tumor vaccine (17) .
By studying these two populations of mature and immature dendritic cells in the cervical lesions, it is hoped that more information on the effects of neoplastic cells on the immune response in general, and dendritic cells in particular, can be gathered.
OBJECTIVES General Objective
To study mature and immature dendritic cell infiltrating density in different cervical lesions
Specific Objective
To determine the effects of neoplastic and dysplastic cells on the dendritic cell infiltrating density
MATERIALS AND METHODS

Study Design
This is a retrospective observational study of dendritic cell maturation in the cervical lesions. The specimens were obtained from Department of Pathology, Hospital University Kebangsaan Malaysia and studied using immunohistochemical method. The sample consists of large punch biopsies and core biopsies from 30 cases of squamous cell carcinoma of the cervix, 29 cases of severe cervical dysplasia, and 30 cases of normal cervix taken from hysterectomy specimens for causes other than cervical lesions.
Study Population
The populations studied were patients in HUKM who were diagnosed with cervical lesions between the years 2000 and 2004 (5 years).
Selection Eligibility
All diagnosed high-grade Cervical Intraepithelial Neoplasia (CIN 3), squamous cell carcinoma of the cervix and nonneoplastic cervix in Hospital Universiti Kebangsaan Malaysia were included. Excluded from the study were other types of cervical carcinoma such as adenocarcinoma, adenosquamous carcinoma, adenoid cystic carcinoma, adenoid basal carcinoma, neuroendocrine tumours, and undifferentiated carcinoma. Small biopsies were also excluded as the study required the evaluation of 30 high-power fields.
IMMUNOHISTOCHEMISTRY Primary Antibodies
Mouse antihuman CD1a (Model M357101) only. Positive controls were included in every batch of tests. All the immunostained slides, were reviewed by two observers independently. The normal tonsil was used as a positive control.
Method for Immunohistochemistry
Paraffin blocks were sectioned at 3 Y 4 micrometer thickness, mounted on sialinized slides, and placed in the oven for 30 minutes. Sections were then deparaffinized with 2 changes of xylene at 3 minutes each, and subsequently rehydrated in 4 changes of decreasing concentrations of alcohol at 3 minutes per change. They were then rinsed in water.
The sections were placed in the target retrieval solution in a microwave at 100-C for 20 minutes, then left to cool at room temperature for 20 minutes. They were washed in water, then placed in 3% hydrogen peroxide for 5 to 10 minutes and washed again. They were then placed in Tris-Buffer solution (TBS) for 3 changes at 3 minutes each and the excess TBS dabbed off.
A drop of the primary antibody in an optimized dilution was added and incubated at room temperature for 30 minutes, then washed in 3 changes of TBS at 3 minutes each. A drop of Envision Detection Kit Peroxidase/DAB (Diaminobenzidine) was then spread over the sections for 7 minutes, after which it was rinsed in water. The EnVisioni reagent of this kit is a peroxidase-conjugated polymer backbone, which carries secondary antibody molecules directed against rabbit and mouse immunoglobulins. The sections were counterstained with hematoxylin, dehydrated in increasing concentrations of alcohol, and mounted.
EVALUATION OF RESULT Dendritic Cell Count
Cell counting was done using Olympus BX40 microscope at magnification of 400 (Â40 objective and Â10 eyepiece). Observation of the intensity of staining was by Olympus UPlanFL 40Â magnification objective lens. Cells displaying membrane staining, cytoplasmic staining, and appropriate morphological features were included. The number of positive cells within 30 highpower fields were counted and expressed as a mean per one high-power field, which is an area of 0.274 mm 2 . As 
FIG. 2. CD83 positive dendritic cells in CIN3 (A) and in SCC (B).
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Statistical Methods
The difference in the counts of Langerhans cells between the normal and CIN3, normal and SCC, and between SCC and CIN3 were evaluated. The significance of the difference was analysed using MannWhitney Test for two independent samples with the level of significance at 95% (P value G 0.05).
RESULTS
Immature dendritic cells are characterized by the CD1a expression (6) . The majority of the CD1a positive dendritic cells were identified at the basal and midzone region of the squamous epithelial layer in the normal cervix. The stromal layer showed fewer cells with positive CD1a staining. The mean dendritic cell density of CD1a in normal ectocervix was 3.89 cells per HPF (SD 2.63), in CIN3 was 3.12 cells per HPF (SD 1.81) (Fig. 1A ) and in squamous cell carcinoma was 2.32 cells per HPF (SD 1.74) (Fig. 1B) .
Mature dendritic cells are characterized by the expression of CD83 (6). The mature CD83 positive dendritic cells were seen at the peritumoral area. The mean dendritic cell density with CD83 in normal ectocervix was 0.0143 cells per HPF (SD 0.035), in CIN3 was 0.0769 cells per HPF (SD 0.125) ( Fig. 2A ) and in squamous cell carcinoma was 0.042 cells per HPF (SD 0.08015) (Fig. 2B ). All controls gave satisfactory results. Table 1 shows the number of dendritic cells expressing CD1a and CD83 molecules in the normal, CIN3 and squamous cell carcinoma of the cervix.
Statistical Analysis
There was statistical significance in CD1a population of dendritic cells between SCC lesions and normal Normal against CIN3 P = 0.295 P = 0.011 Normal against SCC P = 0.009 P = 0.248 CIN3 against SCC P = 0.072 ectocervix (p = 0.009). However there was no statistical significance between CIN3 lesions and normal and between CIN3 and SCC lesions. There was statistical significance in CD83 population of dendritic cells between CIN3 lesions and normal ectocervix (P = 0.011). However there was no statistical significance seen between SCC lesions and normal and between SCC and CIN3 lesions ( Table 2) .
DISCUSSION
The maturation of the antigen presenting cells is one of the most important steps for an immune response towards cancerous cells. In the development of cervical neoplasm, where HPV is confined to the epithelium, the presence and maturation of the dendritic cells are vital for the initiation of the tumoricidal response against the progression towards an increasing degree of dysplasia and ultimately invasive cancers. This study examines the immature and mature dendritic cell density using CD1a and CD83 antibody, respectively.
Our population of CD1a + Langerhans cells concentrated within the epithelial layer of the ectocervix. This is comparable to the findings by HHB Morris et al. in his original study describing Langerhans' cells in the human cervical epithelium (18) . Similarly WAJ Poppe et al. noted CD1a
+ Langerhans cells to be confined within the epithelium as seen in the normal skin (19) .
In our CIN III lesions, we found the number of CD1a + Langerhans cells amongst the neoplastic epithelium to be reduced (mean 3.12/HPF) as compared to the normal ectocervix (mean 3.89/HPF). This correlates well with the findings by F Mota et al. where they noted a progressive decrease in the number of Langerhans cells expressing CD1a with increasing severity of neoplasia (20) . Other researchers have also noted the reduction in the Langerhans cells in HPV lesions and CIN grades II and III (13, 14) . We also observed that the number of CD1a + dendritic cells in our cases of squamous cell carcinoma (mean 2.42 cells/HPF) to be much lower than in the normal (mean 3.89 cells/HPF) and CIN3 (mean 3.12 cells/HPF).
In this study, the mean population of CD83 + cells observed within the normal cervical samples is 0.014/ HPF. Only 7 of 30 samples showed the presence of CD83 + cells within the stromal component. The mean CD83 + population in the cervical intraepithelial neoplasia was higher than the mean population in the normal cervical epithelium and is statistically significant (P value = 0.011). As mature dendritic cells are important antigen presenters, these observations suggest the existence of an active immune response even in the CIN3 lesions, hence, preventing the progression of the intraepithelial neoplasia to invasive carcinoma. This will also explain the natural history of cervical intraepithelial neoplasia, where 33% of CIN3 will regress and only about 12% will progress to invasion (21) .
We found that the population of mature CD83 + dendritic cells declined from a mean of 0.077/HPF in CIN3 to a mean value of 0.042/HPF in squamous cell carcinoma. However, the latter population is still relatively higher than the mature dendritic cell population present in the normal ectocervix (0.0143/HPF). The mean density in one high power field is low; the reason being, in some of the cases there were no CD83 + cells in all the 30 high power fields.
Based on dendritic cell biology, our finding of reducing population of immature DC's with increased severity of neoplasia as well as the increase in mature DC's suggest that there is maturation of dendritic cells in both CIN3 and SCC. The lower population of mature dendritic cells within the SCC as compared to CIN3 suggest that the presence of antigen presenting cells within the carcinoma population is insufficient to mount adequate immune response to prevent invasion into the stroma (22) . This finding also suggests the presence of DC maturation blocking agents within the malignant squamous cell population.
Compartmentalization of the CD1a and CD83 has been described in studies which observed immature dendritic cells residing within the tumor mass whereas mature dendritic cells are located in the peritumoral areas (6) . This finding has also been demonstrated in this study.
In summary, our study showed that there is a decline in the number of immature CD1a + dendritic cells in CIN3 and a further decline in population in the SCC. However there is a significant increase in the mature CD83 + dendritic cells population in the CIN3 and SCC sample as compared to the normal ectocervix. The reducing population of immature DC's as the severity of neoplasia increases together with the rise in mature DC's suggest that there is maturation of dendritic cells in both CIN3 and SCC. The difference in the increased number of mature dendritic cell population between SCC and CIN3, being statistically significant in CIN3, suggest the presence of dendritic cell maturation blocking agents within the malignant population which render the immune response insufficient to prevent invasion.
CONCLUSION
There is a progressive decrease in the immature dendritic cells as the severity of neoplasia increases. In contrast, although the significant increase is demonstrated only in CIN3, there is an increase in the mature dendritic cell population in both the neoplastic lesion.
